Blue Bell Private Wealth Management, LLC Gilead Sciences, Inc. Transaction History
Blue Bell Private Wealth Management, LLC
- $500 Million
- Q4 2024
A detailed history of Blue Bell Private Wealth Management, LLC transactions in Gilead Sciences, Inc. stock. As of the latest transaction made, Blue Bell Private Wealth Management, LLC holds 148 shares of GILD stock, worth $14,131. This represents 0.0% of its overall portfolio holdings.
Number of Shares
148
Previous 181
18.23%
Holding current value
$14,131
Previous $15,000
13.33%
% of portfolio
0.0%
Previous 0.0%
Shares
8 transactions
Others Institutions Holding GILD
# of Institutions
1,993Shares Held
993MCall Options Held
10.1MPut Options Held
8.85M-
Black Rock Inc. New York, NY121MShares$11.5 Billion0.19% of portfolio
-
Vanguard Group Inc Valley Forge, PA116MShares$11 Billion0.19% of portfolio
-
Capital World Investors Los Angeles, CA76.5MShares$7.31 Billion1.03% of portfolio
-
Capital Research Global Investors Los Angeles, CA61.8MShares$5.9 Billion1.12% of portfolio
-
State Street Corp Boston, MA60.2MShares$5.75 Billion0.21% of portfolio
About GILEAD SCIENCES, INC.
- Ticker GILD
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 1,253,369,984
- Market Cap $120B
- Description
- Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...